itan area, 100 polymorphic markers were surveyed for allelic association (Plomin et al., 1994; Plomin et al., 1995) . Of these, eleven showed significant differences in frequency between the low-and high-IQ groups (twice the number expected by chance). However, in an unrelated replication sample only one of these polymorphic markers (EST00083) showed a significant association. Further investigation revealed that this marker is a mitochondrial polymorphism, resulting from the loss of a Mspl restriction site (Mspl-) at position 15,925 of the mitochondrial genome (Anderson et al., 1981) . Apart from obvious questions relating to the mechanism by which a mitochondrial polymorphism may show a relationship with IQ score, the presence of such an association also raises some population genetics issues.
The inheritance of Mitochondrial DNA (mtDNA) is exclusively maternal because the mitochondria are located in the cytoplasm and mature sperm contain very little cytoplasm with few mitochondria. In addition, the mitochondrial genome is not generally believed to undergo intragenic recombination and as such can be considered as a totally linked genetic system. In the absence of recombination, a causative link can only be made between a mitochondrial polymorphism and a phenotypic character such as IQ if either; (a) a considerable amount of functional information exists about both the mutation and the measured phenotypic character, or (b) the polymorphism has arisen independently in several different mitochondrial lines (lineages) and is associated with the measured phenotypic character in all lineages.
The 16,569 base-pair (bp) mammalian mitochondrial genome encodes two ribosomal RNA genes, 22 transfer RNAs (tRNAs) and 13 polypeptides that are parts of multi-subunit enzymes involved in cellular energy metabolism (oxidative phosphorylation). The noncoding sequence is confined to a 1,122bp region known as the control region (CR). This region is the most variable part of the mitochondrial genome and is phylogenetically informative when comparing closely related maternal lineages such as those within our own species (Ward, Frazier, Dewjager, & Paabo, 1991; Richards et al., 1996) .
We have investigated the CR sequences associated with the MspI-individuals from a number of geographically distinct populations in order to address the following questions: (a) has this polymorphism occurred more than once in human history? (b) does this polymorphism show an uneven distribution between populations? (c) does this polymorphism show an association with any other mitochondrial DNA (mtDNA) markers, and (d) how old are the mtDNA lineage(s) that contain this polymorphism. Our sample comprises 144 individuals from the British Isles, 65 individuals from Island Southeast Asia and the Pacific, 7 individuals from France and 48 individuals from Mongolia.
METHOD
The European CR sequences are described in Miller (1996) and for Southeast Asian and Pacific DNA samples in Flint, Boyce, Martinson, & Clegg, (1989) . DNA was extracted from the blood of Mongolian individuals using the method of Boom et al (1990) . Full details of the DNA extraction, PCR amplification and sequencing can be obtained from the first author. Phylogenetic trees were constructed, and the age of common nodes (in mutational time) were estimated using the two-cluster test (Takezaki, Rzhetsky, & Nei, 1995) . In this method, the age of a common node is calculated to be the average genetic distance between all sequence pairs on a phylogenetic tree that are connected by that common node.
Genetic distances were estimated using the nucleotide substitution model of Tamura and Nei (1993) , which assumes different mutation rates for different types of substitution, and compensates for unequal base compositions. To correct for substitution rate heterogeneity at different sites in the CR, a gamma correction was employed. A gamma parameter of 0.47, a value previously estimated for human CR sequences (Wakeley, 1993) , was used. Mutational time estimates were converted into real time estimates by assuming a CR nucleotide divergence rate of 33% per million years (Ward et al., 1991) .
RESULTS
Of the total sample, 12 individuals were found to have the Mspl-polymorphism, of which 10 were from Europe and 2 were from Mongolia. The frequency of Mspl-in our European populations (8.3%) is just significantly lower (Z(~/f=I) =3.92; p<0.05) than the 14% found in the combined high-, medium-and low-IQ sample . Other researchers have found the MspI-polymorphism present at a frequency of about 12% in Europe (L.
Hill, personal communication). Thus it is likely that the lower frequency in our sample occurs because most of our European sample originated from the British Isles. Alternatively the frequency difference may reflect the effects of random genetic drift during the settlement of the USA by European populations. change. In addition, nine out of the ten Europeans have a C to T transition at position 16,294. In a recent survey of European mtDNA-CR sequences these two transitions were found to be diagnostic for a major lineage group (group 2B) that is though to have expanded in Europe with the arrival of the first modem humans about 35,000 years ago (Richards et al., 1996) . It is thought that this lineage group derived from the most common mtDNA type (haplotype) in Europe which had a CR sequence between positions 16,024 and 16,400 that is identical to the reference sequence (Anderson et al., 1981) . Moreover, the T to C transition at position 16,126 most likely preceded the C to T transition at position 16,294. However, Richards et al., (1996) have also suggested that group 2B forms only one branch of a broader lineage group (group 2) and that a second branch (group 2A; which is characterized by T to C transitions at positions 16,126 and 16,069) is also common throughout Europe. Many of the CR sequences for our European samples were already known (Miller, 1996) and it was found that of the 16 samples containing T to C transitions at positions 16,126 and 16,069, none had the MspI-(15,925) polymorphism. If one assumes the one European sample containing a transition at position 16,126, but not at 16,294, is not the result of a back mutation at position 16,294, then our data suggest that the European Mspllineage arose after the formation of lineage group 2 but before the formation of group 2B (Richards et al., 1996) .
We have estimated the age of the common node for our European MspI-CR sequences to be 37,000 years (SE 17.6%). This is in close agreement with the estimated age for lineage group 2B (Richards et al., 1996) and coincides with the date for the colonization of Europe by modern humans (Lahr & Foley, 1994) . These sequences clustered with our 16
MspI+ CR sequences that contained transitions at positions 16,069 and 16,126 to form a lineage group that excluded the two Mongolian MspI-CR sequences and was connected to a common node dating to 60,000 years bp. The common node connecting all MspIsequences dates to 80,000 years where as the common node connecting the two Mongolian CR sequences dates to around 68,000 years. Richards et al., (1996) have shown lineage group 2B to be distributed evenly in Europe at a frequency of about 8% although it was not found in Finland (n=29), Turkey (n=22) or Iceland (n=14). They have postulated that this group arose from an ancestral haplotype containing a transition at position 16,126 and that this haplotype originated, and is still common in the Middle East but not elsewhere. Taken together these data strongly suggest that the MspI-polymorphism arose independently in Europe and Mongolia.
DISCUSSION
With the identification of highly polymorphic markers throughout the human genome, both in nuclear and mitochondrial DNA, it has become possible to search for genes which are responsible for some common multifactorial traits or for susceptibility for common multifactorial diseases. Two main types of analysis are used, either association or linkage analysis. Association studies seek to find the correlated occurrence of specific alleles at a genetic locus and the disease (or trait) in a population. In contrast, linkage studies search for the co-transmission, in families, of a marker locus (regardless of the specific allele at that locus), with the disease or trait. colleagues (1994, 1995) made use of the association method when examining the relationship between 100 polymorphic markers and high and low IQ groups from Cleveland, Ohio. They found significantly more associations than expected by chance alone while a separate study revealed an association with only one polymorphic marker, EST00083. This marker was later shown to be a mitochondrial polymorphism. The entire 16,569 base-long mitochondrial chromosome sequence is known (Anderson et al., 1981) and this polymorphic marker results from the loss of a MspI restriction site (MspI-) at position 15,925 of the mitochondrial genome.
The presence of a MspI-mutation has been previously demonstrated in Caucasian (Johnson, Wallace, Ferris, Rattazzi, & Cavalli-Sforza, 1983; Santachiara Benerecetti, Scozzari, Semino, Torroni, Brega, & Wallace, 1988; Benedictis, Rose, Passarino, & Quagliariello, 1989; Semino, Torroni, Scozzari, Brega, & Santachiara Benerecetti, 1991) and
Oriental (Johnson et al., 1983; Semino et al., 1991) populations but MspI-has not been found in a sub-Saharan African sample (Johnson et al., 1983) . There is good reason to suspect that the Caucasian and Oriental MspI-mutations are not the same since the above researchers have also found differences between the MspI-banding patterns. Our results also suggest Caucasian and Oriental MspI-haplotypes differ in origin. In addition more than one polymorphism has been found that results in the loss of the MspI site at position 15, 925 (Hill, personal communication) . Considering the central role that mtDNA gene products play in the energy metabolism of the cell, a causative link between mtDNA mutations and cognitive ability remains a strong possibility. Apart from the existence of a number of neuro-degenerative diseases associated with mtDNA lesions (Wallace, 1992; Shoffner & Wallace, 1994) , there is a case in which a patient's IQ was found to increase by 20 points upon treatment for mitochondrial dysfunction (Anezaki, Yanagisawa, Ibayashi, & Miyatake, 1992) .
Assuming that most of children used in the original IQ-QTL study (Plomin et al., 1994) are of European maternal ancestry, our work suggests that the MspI-individuals belong to an mtDNA lineage previously labeled 2B (Richards et al., 1996) . Consequently if there is an mtDNA polymorphism that is causally linked with IQ in their sample, then it could occur anywhere on the mtDNA molecule and need only be associated with the 2B lineage in order to explain the results of Skuder and co-workers (1995) . As a result, the ability or inability to detect an association between IQ and mtDNA will depend upon which mitochondrial line(s) (lineage(s)) occurs in the study population. Failure to corroborate the results of Plomin et al (1994) with IQ but that a putative polymorphism causing low IQ in the original Cleveland sample (Plomin et al., 1994) occurs elsewhere on the mitochondrial genome and in only a sub-set of the Mspl-haplotypes in that population. The diversity of MspI-haplotypes in the original Cleveland sample (Plomin et al., 1994 ) has yet to be reported. Given that founder effects would have reduced genetic diversity and affected the distribution of Mspl-haplotypes, it remains a strong possibility that many of the MspI-individuals in this sample belong to a sub-lineage that includes a mitochondrial polymorphism that causes low IQ. We suggest that sequencing of the mtDNA CR in Mspl-individuals from the original Cleveland sample would prove invaluable in identifying such a polymorphism. Such an approach would prove extremely useful in any QTL project in which a link is suspected between mitochondrial mutations and phenotype.
